 | • レポートコード：MRC2102QY6587 • 出版社/出版日：QYResearch / 2021年1月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：材料、化学 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のヒルジン市場について種類別（天然ヒルジン、組換えヒルジン）、用途別（血栓症、腫瘍性疾患、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ヒルジン市場の概要 ・世界の主要地域別ヒルジン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヒルジン市場規模2015-2026：種類別（天然ヒルジン、組換えヒルジン） ・世界のヒルジン市場規模2015-2026：用途別（血栓症、腫瘍性疾患、その他） ・ヒルジンの米国市場規模2015-2020 ・ヒルジンのヨーロッパ市場規模2015-2020 ・ヒルジンの中国市場規模2015-2020 ・ヒルジンの日本市場規模2015-2020 ・ヒルジンの東南アジア市場規模2015-2020 ・ヒルジンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ヒルジンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒルジンの市場動向・機会・課題 ・調査の結論 |
This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin.
Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
Market Analysis and Insights: Global Hirudin Market
The global Hirudin market size is projected to reach US$ 4289 million by 2026, from US$ 3720.1 million in 2020, at a CAGR of 2.4% during 2021-2026.
Global Hirudin Scope and Market Size
The global Hirudin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hirudin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Hirudin market is segmented into
Natural Hirudin
Recombinant Hirudin
Segment by Application, the Hirudin market is segmented into
Thrombosis Disease
Tumor Disease
Others
The Hirudin market is analysed and market size information is provided by regions (countries). Segment by Application, the Hirudin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hirudin Market Share Analysis
Hirudin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hirudin business, the date to enter into the Hirudin market, Hirudin product introduction, recent developments, etc.
The major vendors covered:
The Medicines Company
Keyken
Minapharm
Abbott
SALUBRIS
Pfizer, Inc
Teva Pharmaceutical Industries Ltd
DUOPUTAI
Pentapharm
1 Hirudin Market Overview
1.1 Hirudin Product Scope
1.2 Hirudin Segment by Type
1.2.1 Global Hirudin Sales by Type (2020-2026)
1.2.2 Natural Hirudin
1.2.3 Recombinant Hirudin
1.3 Hirudin Segment by Application
1.3.1 Global Hirudin Sales Comparison by Application (2020-2026)
1.3.2 Thrombosis Disease
1.3.3 Tumor Disease
1.3.4 Others
1.4 Hirudin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Hirudin Sales Growth Rate (2015-2026)
1.4.2 Global Hirudin Revenue and Growth Rate (2015-2026)
1.4.3 Global Hirudin Price Trends (2015-2026)
2 Hirudin Estimate and Forecast by Region
2.1 Global Hirudin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Hirudin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Hirudin Sales Market Share by Region (2015-2020)
2.2.2 Global Hirudin Revenue Market Share by Region (2015-2020)
2.3 Global Hirudin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Hirudin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Hirudin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Hirudin Estimates and Projections (2015-2026)
2.4.2 Europe Hirudin Estimates and Projections (2015-2026)
2.4.3 China Hirudin Estimates and Projections (2015-2026)
2.4.4 Japan Hirudin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Hirudin Estimates and Projections (2015-2026)
2.4.6 India Hirudin Estimates and Projections (2015-2026)
3 Global Hirudin Competition Landscape by Players
3.1 Global Top Hirudin Players by Sales (2015-2020)
3.2 Global Top Hirudin Players by Revenue (2015-2020)
3.3 Global Hirudin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hirudin as of 2019)
3.4 Global Hirudin Average Price by Company (2015-2020)
3.5 Manufacturers Hirudin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Hirudin Players (Opinion Leaders)
4 Global Hirudin Market Size by Type
4.1 Global Hirudin Historic Market Review by Type (2015-2020)
4.1.1 Global Hirudin Sales Market Share by Type (2015-2020)
4.1.2 Global Hirudin Revenue Market Share by Type (2015-2020)
4.1.3 Global Hirudin Price by Type (2015-2020)
4.2 Global Hirudin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Hirudin Sales Forecast by Type (2021-2026)
4.2.2 Global Hirudin Revenue Forecast by Type (2021-2026)
4.2.3 Global Hirudin Price Forecast by Type (2021-2026)
5 Global Hirudin Market Size by Application
5.1 Global Hirudin Historic Market Review by Application (2015-2020)
5.1.1 Global Hirudin Sales Market Share by Application (2015-2020)
5.1.2 Global Hirudin Revenue Market Share by Application (2015-2020)
5.1.3 Global Hirudin Price by Application (2015-2020)
5.2 Global Hirudin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Hirudin Sales Forecast by Application (2021-2026)
5.2.2 Global Hirudin Revenue Forecast by Application (2021-2026)
5.2.3 Global Hirudin Price Forecast by Application (2021-2026)
6 United States Hirudin Market Facts & Figures
6.1 United States Hirudin Sales Market Share by Company (2015-2020)
6.2 United States Hirudin Sales Market Share by Type (2015-2020)
6.3 United States Hirudin Sales Market Share by Application (2015-2020)
7 Europe Hirudin Market Facts & Figures
7.1 Europe Hirudin Sales Market Share by Company (2015-2020)
7.2 Europe Hirudin Sales Market Share by Type (2015-2020)
7.3 Europe Hirudin Sales Market Share by Application (2015-2020)
8 China Hirudin Market Facts & Figures
8.1 China Hirudin Sales Market Share by Company (2015-2020)
8.2 China Hirudin Sales Market Share by Type (2015-2020)
8.3 China Hirudin Sales Market Share by Application (2015-2020)
9 Japan Hirudin Market Facts & Figures
9.1 Japan Hirudin Sales Market Share by Company (3015-3030)
9.2 Japan Hirudin Sales Market Share by Type (2015-2020)
9.3 Japan Hirudin Sales Market Share by Application (2015-2020)
10 Southeast Asia Hirudin Market Facts & Figures
10.1 Southeast Asia Hirudin Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Hirudin Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Hirudin Sales Market Share by Application (2015-2020)
11 India Hirudin Market Facts & Figures
11.1 India Hirudin Sales Market Share by Company (2015-2020)
11.2 India Hirudin Sales Market Share by Type (2015-2020)
11.3 India Hirudin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Hirudin Business
12.1 The Medicines Company
12.1.1 The Medicines Company Corporation Information
12.1.2 The Medicines Company Business Overview
12.1.3 The Medicines Company Hirudin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 The Medicines Company Hirudin Products Offered
12.1.5 The Medicines Company Recent Development
12.2 Keyken
12.2.1 Keyken Corporation Information
12.2.2 Keyken Business Overview
12.2.3 Keyken Hirudin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Keyken Hirudin Products Offered
12.2.5 Keyken Recent Development
12.3 Minapharm
12.3.1 Minapharm Corporation Information
12.3.2 Minapharm Business Overview
12.3.3 Minapharm Hirudin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Minapharm Hirudin Products Offered
12.3.5 Minapharm Recent Development
12.4 Abbott
12.4.1 Abbott Corporation Information
12.4.2 Abbott Business Overview
12.4.3 Abbott Hirudin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Abbott Hirudin Products Offered
12.4.5 Abbott Recent Development
12.5 SALUBRIS
12.5.1 SALUBRIS Corporation Information
12.5.2 SALUBRIS Business Overview
12.5.3 SALUBRIS Hirudin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 SALUBRIS Hirudin Products Offered
12.5.5 SALUBRIS Recent Development
12.6 Pfizer, Inc
12.6.1 Pfizer, Inc Corporation Information
12.6.2 Pfizer, Inc Business Overview
12.6.3 Pfizer, Inc Hirudin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Pfizer, Inc Hirudin Products Offered
12.6.5 Pfizer, Inc Recent Development
12.7 Teva Pharmaceutical Industries Ltd
12.7.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.7.2 Teva Pharmaceutical Industries Ltd Business Overview
12.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Teva Pharmaceutical Industries Ltd Hirudin Products Offered
12.7.5 Teva Pharmaceutical Industries Ltd Recent Development
12.8 DUOPUTAI
12.8.1 DUOPUTAI Corporation Information
12.8.2 DUOPUTAI Business Overview
12.8.3 DUOPUTAI Hirudin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 DUOPUTAI Hirudin Products Offered
12.8.5 DUOPUTAI Recent Development
12.9 Pentapharm
12.9.1 Pentapharm Corporation Information
12.9.2 Pentapharm Business Overview
12.9.3 Pentapharm Hirudin Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Pentapharm Hirudin Products Offered
12.9.5 Pentapharm Recent Development
13 Hirudin Manufacturing Cost Analysis
13.1 Hirudin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hirudin
13.4 Hirudin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hirudin Distributors List
14.3 Hirudin Customers
15 Market Dynamics
15.1 Hirudin Market Trends
15.2 Hirudin Opportunities and Drivers
15.3 Hirudin Market Challenges
15.4 Hirudin Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Hirudin Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Hirudin Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Hirudin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Hirudin Sales (MT) by Region (2015-2020)
Table 5. Global Hirudin Sales Market Share by Region (2015-2020)
Table 6. Global Hirudin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Hirudin Revenue Share by Region (2015-2020)
Table 8. Global Hirudin Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Hirudin Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Hirudin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Hirudin Revenue Share Forecast by Region (2021-2026)
Table 12. Global Hirudin (MT) of Key Companies (2015-2020)
Table 13. Global Hirudin Sales Share by Company (2015-2020)
Table 14. Global Hirudin Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Hirudin Revenue Share by Company (2015-2020)
Table 16. Global Hirudin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hirudin as of 2019)
Table 17. Global Hirudin Average Price (USD/Kg) of Key Company (2015-2020)
Table 18. Manufacturers Hirudin Manufacturing Sites and Area Served
Table 19. Manufacturers Hirudin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Hirudin Players
Table 22. Global Hirudin Sales (MT) by Type (2015-2020)
Table 23. Global Hirudin Sales Share by Type (2015-2020)
Table 24. Global Hirudin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Hirudin Price (MT) by Type (2015-2020)
Table 26. Global Hirudin Sales Share by Type (2021-2026)
Table 27. Global Hirudin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Hirudin Revenue Share by Type (2021-2026)
Table 29. Global Hirudin Price (MT) by Type (2021-2026)
Table 30. Global Hirudin Sales (MT) by Application (2015-2020)
Table 31. Global Hirudin Sales Share by Application (2015-2020)
Table 32. Global Hirudin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Hirudin Price (MT) by Application (2015-2020)
Table 34. Global Hirudin Sales (MT) by Application (2021-2026)
Table 35. Global Hirudin Sales Share by Application (2021-2026)
Table 36. Global Hirudin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Hirudin Revenue Share by Application (2021-2026)
Table 38. Global Hirudin Price (MT) by Application (2021-2026)
Table 39. United States Hirudin Sales (MT) by Company (2015-2020)
Table 40. United States Hirudin Sales Market Share by Company (2015-2020)
Table 41. United States Hirudin Sales (MT) by Type (2015-2020)
Table 42. United States Hirudin Sales Market Share by Type (2015-2020)
Table 43. United States Hirudin Sales (MT) by Application (2015-2020)
Table 44. United States Hirudin Sales Market Share by Application (2015-2020)
Table 45. Europe Hirudin Sales (MT) by Company (2015-2020)
Table 46. Europe Hirudin Sales Market Share by Company (2015-2020)
Table 47. Europe Hirudin Sales (MT) by Type (2015-2020)
Table 48. Europe Hirudin Sales Market Share by Type (2015-2020)
Table 49. Europe Hirudin Sales (MT) by Application (2015-2020)
Table 50. Europe Hirudin Sales Market Share by Type (2015-2020)
Table 51. China Hirudin Sales (MT) by Company (2015-2020)
Table 52. China Hirudin Sales Market Share by Company (2015-2020)
Table 53. China Hirudin Sales (MT) by Type (2015-2020)
Table 54. China Hirudin Sales Market Share by Type (2015-2020)
Table 55. China Hirudin Sales (MT) by Application (2015-2020)
Table 56. China Hirudin Sales Market Share by Application (2015-2020)
Table 57. Japan Hirudin Sales (MT) by Company (2015-2020)
Table 58. Japan Hirudin Sales Market Share by Company (2015-2020)
Table 59. Japan Hirudin Sales (MT) by Type (2015-2020)
Table 60. Japan Hirudin Sales Market Share by Type (2015-2020)
Table 61. Japan Hirudin Sales (MT) by Application (2015-2020)
Table 62. Japan Hirudin Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Hirudin Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Hirudin Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Hirudin Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Hirudin Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Hirudin Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Hirudin Sales Market Share by Application (2015-2020)
Table 69. India Hirudin Sales (MT) by Company (2015-2020)
Table 70. India Hirudin Sales Market Share by Company (2015-2020)
Table 71. India Hirudin Sales (MT) by Type (2015-2020)
Table 72. India Hirudin Sales Market Share by Type (2015-2020)
Table 73. India Hirudin Sales (MT) by Application (2015-2020)
Table 74. India Hirudin Sales Market Share by Application (2015-2020)
Table 75. The Medicines Company Corporation Information
Table 76. The Medicines Company Description and Business Overview
Table 77. The Medicines Company Hirudin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 78. The Medicines Company Hirudin Product
Table 79. The Medicines Company Recent Development
Table 80. Keyken Corporation Information
Table 81. Keyken Description and Business Overview
Table 82. Keyken Hirudin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Keyken Hirudin Product
Table 84. Keyken Recent Development
Table 85. Minapharm Corporation Information
Table 86. Minapharm Description and Business Overview
Table 87. Minapharm Hirudin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Minapharm Hirudin Product
Table 89. Minapharm Recent Development
Table 90. Abbott Corporation Information
Table 91. Abbott Description and Business Overview
Table 92. Abbott Hirudin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Abbott Hirudin Product
Table 94. Abbott Recent Development
Table 95. SALUBRIS Corporation Information
Table 96. SALUBRIS Description and Business Overview
Table 97. SALUBRIS Hirudin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. SALUBRIS Hirudin Product
Table 99. SALUBRIS Recent Development
Table 100. Pfizer, Inc Corporation Information
Table 101. Pfizer, Inc Description and Business Overview
Table 102. Pfizer, Inc Hirudin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Pfizer, Inc Hirudin Product
Table 104. Pfizer, Inc Recent Development
Table 105. Teva Pharmaceutical Industries Ltd Corporation Information
Table 106. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 107. Teva Pharmaceutical Industries Ltd Hirudin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Teva Pharmaceutical Industries Ltd Hirudin Product
Table 109. Teva Pharmaceutical Industries Ltd Recent Development
Table 110. DUOPUTAI Corporation Information
Table 111. DUOPUTAI Hirudin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. DUOPUTAI Description and Business Overview
Table 113. DUOPUTAI Hirudin Product
Table 114. DUOPUTAI Recent Development
Table 115. Pentapharm Corporation Information
Table 116. Pentapharm Hirudin Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Pentapharm Description and Business Overview
Table 118. Pentapharm Hirudin Product
Table 119. Pentapharm Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Hirudin Distributors List
Table 123. Hirudin Customers List
Table 124. Hirudin Market Key Trends
Table 125. Hirudin Key Opportunities and Drivers
Table 126. Hirudin Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Hirudin Product Picture
Figure 2. Global Hirudin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hirudin Market Share by Application in 2020 & 2026
Figure 6. Thrombosis Disease Examples
Figure 7. Tumor Disease Examples
Figure 8. Others Examples
Figure 9. Global Hirudin Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Hirudin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Hirudin Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Hirudin Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Hirudin Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Hirudin Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Hirudin Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Hirudin Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Hirudin Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Hirudin Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Hirudin Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Hirudin Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Hirudin Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Hirudin Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Hirudin Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Hirudin Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Hirudin Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Hirudin Players Market Share by Revenue in Hirudin 2015 & 2019
Figure 27. Hirudin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Hirudin Revenue Share by Type (2015-2020)
Figure 29. Global Hirudin Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Hirudin Revenue Share by Application (2015-2020)
Figure 31. Global Hirudin Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Hirudin Sales Market Share by Type in 2019
Figure 33. United States Hirudin Sales Market Share by Type in 2019
Figure 34. Europe Hirudin Sales Market Share by Company in 2019
Figure 35. Europe Hirudin Sales Market Share by Type in 2019
Figure 36. Europe Hirudin Sales Market Share by Application in 2019
Figure 37. China Hirudin Sales Market Share by Company in 2019
Figure 38. China Hirudin Sales Market Share by Type in 2019
Figure 39. China Hirudin Sales Market Share by Application in 2019
Figure 40. Japan Hirudin Sales Market Share by Company in 2019
Figure 41. Japan Hirudin Sales Market Share by Type in 2019
Figure 42. Japan Hirudin Sales Market Share by Application in 2019
Figure 43. Southeast Asia Hirudin Sales Market Share by Company in 2019
Figure 44. Southeast Asia Hirudin Sales Market Share by Type in 2019
Figure 45. Southeast Asia Hirudin Sales Market Share by Application in 2019
Figure 46. India Hirudin Sales Market Share by Company in 2019
Figure 47. India Hirudin Sales Market Share by Type in 2019
Figure 48. India Hirudin Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Hirudin
Figure 51. Manufacturing Process Analysis of Hirudin
Figure 52. Hirudin Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
クローン病治療薬の世界市場レポート2020 Market Analysis and Insights: Global Crohn's Disease Drug Market The global Crohn's Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Crohn's Disease Drug Scope and Market Size The global Crohn's Disease Drug…- 胃食道逆流症（GERD）薬の世界市場レポート2020 Market Analysis and Insights: Global Gastro Esophageal Reflux Disease (GERD) Drug Market The global Gastro Esophageal Reflux Disease (GERD) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Gastro Esophageal Reflux D…
- 慢性腎臓病治療薬の世界市場レポート2020 Market Analysis and Insights: Global Chronic Kidney Disease Drugs Market The global Chronic Kidney Disease Drugs market size is projected to reach US$ 12450 million by 2026, from US$ 11220 million in 2020, at a CAGR of 1.8% during 2021-2026. Global Chronic Kidney Disease Drugs Scope and Market Size …
- 腎疾患治療装置の世界市場レポート2020 Renal Disease Treatment Devices are subdivided into urinary treatment, dialysis, pelvic organ prolapse treatment, endoscopic, benign prostatic hyperplasia treatment equipment, prostate stent, gravel, sacral nerve regulation, urethral insertion and pessary, urethral stent, vaginal network Sleeve and …
- 感染症検査機器の世界市場レポート2020 Infectious Disease Testing Instrumentation is a kind of instrument to diagnose infectious disease, such as HIV, HCV, HBV, HAV, CMV, HPV and so on. In the last several years, China market of Infectious Disease Testing Instrumentation developed year by year, with an average growth rate of 17.36% for t…